Welcome to CDC Stacks | Healthcare professionals warned not to use certain intravenous metronidazole, ondansetron, and ciprofloxacin due to potential contamination - 25223 | Health Alert Network (HAN)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Healthcare professionals warned not to use certain intravenous metronidazole, ondansetron, and ciprofloxacin due to potential contamination
  • Published Date:
    6/1/10
  • Source:
    HAN ; 314
  • Language:
    English
Filetype[PDF - 611.60 KB]


Details:
  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.) ; United States. Food and Drug Administration. ;
  • Series:
    HAN ; 314
  • Keywords:
  • Description:
    Tuesday, June 01, 2010, 10:25 EST (10:25 AM EST)

    CDCHAN-00314-2010-06-01-ADV-N

    The U.S. Food and Drug Administration (FDA) is alerting healthcare professionals not to use certain intravenous (IV) bags of metronidazole, ondansetron, and ciprofloxacin because of potential contamination. FDA has received reports of floating matter in IV bags manufactured by Claris Lifesciences Limited, in Ahmedabad, India. Microbiological analysis identified the matter in one of the bags as a Cladosporium mold. Molds of this type can cause infections in susceptible patients, such as immunocompromised individuals. At this time, FDA is not aware of any reports of injuries due to administration of these products. Affected products include any metronidazole, ondansetron, and ciprofloxacin manufactured by Claris Lifesciences Limited and sold under the following labels: Claris, Sagent Pharmaceuticals, Pfizer, West-Ward Pharmaceuticals

  • Document Type:
    HAN Health Advisory
  • Collection(s):
    Health Alert Network (HAN)
  • Place as Subject:
    gau
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Validation and Application of Models to Predict Facemask Influenza Contamination in Healthcare Settings
    Personal Author:
    Fisher, Edward M.; Noti, John D.; Lindsley, William G.; Blachere, Francoise M.; Shaffer, Ronald E.;
    Published:
    Mar 04 2014
    Source:
    Risk Anal. 2014; 34(8):1423-1434.
    Description:
    Facemasks are part of the hierarchy of interventions used to reduce the transmission of respiratory pathogens by providing a barrier. Two types of facemasks used by healthcare workers are N95 filtering facepiece respirators (FFRs) and surgical masks ...
    File Type:
    Filetype[PDF - 349.72 KB]
  2. Attributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: a cost analysis
    Personal Author:
    Reynolds, Courtney A; Finkelstein, Jonathan A; Ray, G Thomas; Moore, Matthew R; Huang, Susan S;
    Published:
    May 21 2014
    Source:
    Antimicrob Resist Infect Control. 2014; 3:16.
    Description:
    Background : The burden of disease due to S. pneumoniae (pneumococcus), particularly pneumonia, remains high despite the widespread use of vaccines. Drug resistant strains complicate clinical treatment and may increase costs. We estimated the annual ...
    File Type:
    Filetype[PDF - 790.72 KB]
  3. Coming Soon
    Evaluation of standardized sample collection, packaging, and decontamination procedures to assess cross-contamination potential during Bacillus anthracis incident response operations
    Personal Author:
    Calfee, M. Worth; Tufts, Jenia; Meyer, Kathryn; McConkey, Katrina; Mickelsen, Leroy; Rose, Laura; Dowell, Chad; Delaney, Lisa; Weber, Angela; Morse, Stephen; Chaitram, Jasmine; Gray, Marshall;
    Published:
    Dec 2016
    Source:
    J Occup Environ Hyg. 13(12):980-992.
    Description:
    Sample collection procedures and primary receptacle (sample container and bag) decontamination methods should prevent contaminant transfer between contaminated and non-contaminated surfaces and areas during bio-incident operations. Cross-contaminatio...
    Public Access
    Available on:
    December 01, 2017
  4. Alternatives to Ciprofloxacin Use for Enteric Fever, United Kingdom
    Personal Author:
    Threlfall, E. John; de Pinna, Elizabeth; Day, Martin; Lawrence, Joanne; Jones, Jane;
    Published:
    May 2008
    Source:
    Emerg Infect Dis. 14(5):860-861.
    File Type:
    Filetype[PDF - 96.38 KB]
  5. Remediation and infection control considerations for reopening healthcare facilities closed due to extensive water and wind damage fact sheet
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    May 24, 2007
    Series:
    Hurricanes
    Description:
    During a hurricane or flood, many hospitals may sufferwater and wind damage; somemay have standing water for an extended period of time due to flooding. Building structures, equipment, and supplies may be heavily contaminated with microorganisms such...
    File Type:
    Filetype[PDF - 139.28 KB]